2659 — Shanghai Bao Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$29.27bn
- HK$28.22bn
- CNY49.16m
Annual cashflow statement for Shanghai Bao Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | — |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -160 | -364 | -395 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | -6.27 | 153 | 101 |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 4.02 | -40 | 76.9 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -140 | -220 | -180 |
| Capital Expenditures | -136 | -118 | -153 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 0 | -3.85 | 60.4 |
| Sale of Fixed Assets | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -136 | -122 | -93 |
| Financing Cash Flow Items | -4.29 | -6.97 | -50 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 123 | 543 | 998 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -151 | 202 | 717 |